作者:Eric A. Owens、Hang T. Huynh、Ekaterina M. Stroeva、Arghya Barman、Kostiantyn Ziabrev、Ananya Paul、Sarah V. Nguyen、Matthew Laramie、Donald Hamelberg、Markus W. Germann、W. David Wilson、Maged Henary
DOI:10.1021/acs.bioconjchem.9b00571
日期:2019.10.16
G-Quadruplex DNA has been recognized as a highly appealing target for the development of new selective chemotherapeutics, which could result in markedly reduced toxicity toward normal cells. In particular, the cyanine dyes that bind selectively to G-quadruplex structures without targeting duplex DNA have attracted attention due to their high amenability to structural modifications that allows fine-tuning of their biomolecular interactions. We have previously reported pentamethine and symmetric trimethine cyanines designed to effectively bind G-quadruplexes through end stacking interactions. Herein, we are reporting a second generation of drug candidates, the asymmetric trimethine cyanines. These have been synthesized and evaluated for their quadruplex binding properties. Incorporating a benz[c,d]indolenine heterocyclic unit increased overall quadruplex binding, and elongating the alkyl length increases the quadruplex-to-duplex binding specificity.
G-四链 DNA 被认为是开发新型选择性化疗药物的一个非常吸引人的靶点,这可能显著减少对正常细胞的毒性。特别是,选择性结合 G-四链结构而不针对双链 DNA 的氰染料因其高度适应结构改造而受到关注,这使得对其生物分子相互作用进行微调成为可能。我们之前报道了设计用于通过末端堆叠相互作用有效结合 G-四链的五甲基和对称三甲基氰染料。在这里,我们报告了一种第二代药物候选物,即不对称三甲基氰染料。这些化合物已经合成并评估了它们的四链结合属性。引入苯[c,d]吲哚啉杂环单元提高了整体四链结合能力,而延长烷基链的长度则增加了四链与双链的结合特异性。